App-Quantinova.ai

INCREASED LEVELS OF THROMBIN ACTIVATABLE FIBRINOLYSIS INHIBITOR - TAFI CORRELATE WITH COMPLEMENT ACTIVATION IN PATIENTS WITH THE ANTIPHOSPHOLIPID SYNDROME

A. Antovic - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Evithrom

THE PREVALENCE AND PATTERNS OF ANTIPHOSPHOLIPID ANTIBODIES IN SLE AND NON-SLE PATIENTS WITH END STAGE RENAL DISEASE

A. Broder - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Nephrology

Venous thrombosis

N/A

ULTRASONOGRAPHIC EVALUATION OF RENAL ARTERIES IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME: FOCUS ON RESISTIVE INDEX AND STENOSIS

C. Perricone - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Mofezolac

NEURODEVELOPMENTAL LONG TERM OUTCOME IN CHILDREN BORN TO MOTHERS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND ANTIPHOSPHOLIPID SYNDROME

C. Nalli - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

PREGNANCY OUTCOMES IN A COHORT OF WOMEN WITH SLE. LONG TERM 20 YEARS OBSERVATION

D. Tegzova - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Cyclosporine A

DEEP VEIN THROMBOSIS IN PATIENTS WITH ANTIPHOSPHOLIPIDIC SYNDROME AND LUPUS: THE ROLE OF SYSTEMIC INFLAMMATION

S. Caraiola - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Fibrinogen (IV)

PRIMARY DISEASE OF THE RESPIRATORY SYSTEM IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

H. Borrell - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Cyclophosphamide

COMPARISON OF THE CLINICAL FEATURES BETWEEN PATIENTS WITH PRIMARY AND SECONDARY ANTIPHOSPHOLIPID SYNDROME: RESULTS FROM THE SERBIAN NATIONAL COHORT STUDY

L. Stojanovich - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

DYSLIPIDEMIA IS ASSOCIATED WITH VENOUS THROMBOSIS IN PATIENT WITH PRIMARY ANTI ANTIPHOSPHOLIPID SYNDROME. A STUDY OF COMORBIDITIES AND COMPLICATIONS

L. J. Jara - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Aspirin

THROMBOSIS RISK FACTORS IN PATIENTS WITH RHEUMATOID ARTHRITIS AND SYSTEMIC LUPUS ERYTHEMATOSUS WITH/WITHOUT ANTIPHOSPHOLIPID SYNDROME

M. A. Satybaldyeva - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Glucocorticoid

PATIENTS WITH LONG-STANDING PRIMARY ANTIPHOSPHOLIPID SYNDROME: RETROSPECTIVE ANALYSIS OF RECURRENCES, ORGAN DAMAGE AND MORTALITY

R. Reggia - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

WHAT IS THE PREVALENCE OF NON CRITERIA ANTIPHOSPHOLIPID ANTIBODIES IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME?

V. Rodriguez-Garcia - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

annexin A5

THROMBOPOIETIN IN SLE: CORRELATIONS WITH CLINICAL AND LABORATORY PARAMETERS. A CROSS-SECTIONAL STUDY

C. L. Lu - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

PLASMA LEVELS OF PF-4VAR/CXCL4L1, A NON ALLELIC VARIANT OF PLATELET FACTOR-4 (PF-4/CXCL4), ARE ELEVATED IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME (APS)

M. P. Sikara - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

THROMBOSPONDIN 1, AN ANTIANGIOGENIC AND PROAPOPTOTIC FACTOR, IS ELEVATED IN THE PLASMA OF PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME

M. D. Patsouras - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

A DELPHI EXERCISE FOR TREATMENT ALGORITHMS FOR SYSTEMIC LUPUS ERYTHEMATOSUS

J. E. Pope - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

Mycophenolate mofetil

NON-THROMBOTIC PRIMARY ANTIPHOSPHOLIPID KIDNEY DISEASE, LONGITUDINAL FOLLOW UP AND TREATMENT RECOMENDATIONS

L. Olguin - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Angiotensin II

NEUTROPHIL LYMPHOCYTE RATIO CAN BE A VALUABLE MARKER IN DEFINING DISEASE ACTIVITY IN PATIENTS WITH AS

Y. Pehlivan - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

HOW TO OPTIMIZE DOPPLER SETTINGS FOR FAST FLOW

W. A. Schmidt - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

HOW TO OPTIMIZE DOPPLER SETTINGS FOR FAST FLOW

W. A. Schmidt - European League Against Rheumatism (EULAR) , 2014

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Filters

7277 Abstracts